Product Information
VERAPAMIL SR 240 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.5397 per EA under NDC 00591288401. Its NADAC has been published 662 times since Nov 28, 2013.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
240 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00591288401
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 240 MG CAPSULE has been published 662 times since Nov 28, 2013, and over the history we have for it it has risen 126.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5397 per EA |
|---|---|
| All-time high | $2.7190 (Apr 15, 2026) |
| All-time low | $0.6094 (Feb 18, 2015) |
| 52-week high | $2.7190 |
| 52-week low | $1.1423 |
| Median price | $1.3665 |
| Average price | $1.3052 |
| Largest weekly change | +72.9% (May 20, 2015) |
| Weeks tracked | 662 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
+34.8%
3M
-15.4%
6M
-37.1%
1Y
+39.9%
3Y
+15.0%
5Y
+3.2%
All
+126.4%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 240 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 240 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $1.5397 per EA (NDC 00591288401), effective Jul 29, 2026.
How has the price of VERAPAMIL SR 240 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 240 MG CAPSULE has risen 126.4%. It has been tracked across 662 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 240 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL SR 240 MG CAPSULE has ranged from a low of $0.6094 (Feb 18, 2015) to a high of $2.7190 (Apr 15, 2026), with a median of $1.3665 per EA.
Are there cheaper alternatives to VERAPAMIL SR 240 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VERAPAMIL SR 240 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VERAPAMIL SR 240 MG CAPSULE?
VERAPAMIL SR 240 MG CAPSULE (NDC 00591288401) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.